Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Stratec SE

STSEYPNK
Healthcare
Medical - Devices
$5.10
$0.00(0.00%)
U.S. Market opens in 14h 46m

Stratec SE Fundamental Analysis

Stratec SE (STSEY) shows weak financial fundamentals with a PE ratio of 83.84, profit margin of 6.09%, and ROE of 6.55%. The company generates $0.3B in annual revenue with weak year-over-year growth of -1.64%.

Key Strengths

Current Ratio4.19

Areas of Concern

ROE6.55%
Cash Position1.55%
PEG Ratio20.79
We analyze STSEY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 39.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
39.5/100

We analyze STSEY's fundamental strength across five key dimensions:

Efficiency Score

Weak

STSEY struggles to generate sufficient returns from assets.

ROA > 10%
3.63%

Valuation Score

Weak

STSEY trades at a premium to fair value.

PE < 25
83.84
PEG Ratio < 2
20.79

Growth Score

Weak

STSEY faces weak or negative growth trends.

Revenue Growth > 5%
-1.64%
EPS Growth > 10%
4.76%

Financial Health Score

Excellent

STSEY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
4.19

Profitability Score

Weak

STSEY struggles to sustain strong margins.

ROE > 15%
6.55%
Net Margin ≥ 15%
6.09%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is STSEY Expensive or Cheap?

P/E Ratio

STSEY trades at 83.84 times earnings. This suggests a premium valuation.

83.84

PEG Ratio

When adjusting for growth, STSEY's PEG of 20.79 indicates potential overvaluation.

20.79

Price to Book

The market values Stratec SE at 5.47 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.47

EV/EBITDA

Enterprise value stands at 29.31 times EBITDA. This signals the market has high growth expectations.

29.31

How Well Does STSEY Make Money?

Net Profit Margin

For every $100 in sales, Stratec SE keeps $6.09 as profit after all expenses.

6.09%

Operating Margin

Core operations generate 10.62 in profit for every $100 in revenue, before interest and taxes.

10.62%

ROE

Management delivers $6.55 in profit for every $100 of shareholder equity.

6.55%

ROA

Stratec SE generates $3.63 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.63%

Following the Money - Real Cash Generation

Operating Cash Flow

Stratec SE generates limited operating cash flow of $21.85M, signaling weaker underlying cash strength.

$21.85M

Free Cash Flow

Stratec SE generates weak or negative free cash flow of $7.09M, restricting financial flexibility.

$7.09M

FCF Per Share

Each share generates $0.02 in free cash annually.

$0.02

FCF Yield

STSEY converts 0.54% of its market value into free cash.

0.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

83.84

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

20.79

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.47

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.19

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.07

vs 25 benchmark

ROA

Return on assets percentage

0.04

vs 25 benchmark

ROCE

Return on capital employed

0.07

vs 25 benchmark

How STSEY Stacks Against Its Sector Peers

MetricSTSEY ValueSector AveragePerformance
P/E Ratio83.8429.45 Worse (Expensive)
ROE6.55%779.00% Weak
Net Margin6.09%-24930.00% (disorted) Weak
Debt/Equity0.000.26 Strong (Low Leverage)
Current Ratio4.194.65 Strong Liquidity
ROA3.63%-19333.00% (disorted) Weak

STSEY outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Stratec SE's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

14.67%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

9.45%

Industry Style: Defensive, Growth, Innovation

Growing

FCF CAGR

126.01%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ